BioSpace News Archive

Cabiralizumab continues to advance in randomized Phase 2 trial in pancreatic cancer

$1.8 Million in Net Product Sales for TAVALISSE™ (fostamatinib disodium hexahydrate)

Management to Host Conference Call Today at 4:30 p.m. ET

Completed Positive Pivotal Phase 3 Trial for TRC101

Magenta Therapeutics(NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today announced that the Company is scheduled to present at the 2018 Wedbush PacGrow Healthcare Conference on Tuesday, August 14th, at 9:10 a.m. ET.

Verastem, Inc. reported financial results for the quarter ended June 30, 2018 and provided an overview of certain corporate developments.

Southwest Research Institute (SwRI®) is hosting a one-day workshop on October 8, 2018, to address the concepts, strategies and tools needed for a more successful investigational new drug (IND) submission.

Executive Insight Founder and Managing Partner Andrea Sobrio is officially one of the “Most Inspiring People 2018” in the life-sciences industry!

Alpine Immune Sciences, Inc. reported the grant of an equity inducement award to Mark Litton, Ph.D., Alpine’s new President and Chief Operating Officer, effective August 6, 2018.

Accurate Diagnosis and Proper Management Could Improve Outcomes